Larissa Mendes

Pathologist
Uropathology Clinical Research Fellow
UCLH NHS

[El Craque @ElCraque2]

@diegoelison Urgente: Traficrente, amigo do Flávio, mandou fechar igrejas católicas

[Journal of Clinical Investigation @jclinicalinvest]

Reporting on prostate core biopsy data from participants enrolled in the STAMPEDE platform protocol: https://t.co/WheiCjP6Sb

Larissa Mendes @LarissaSTMendes Gerhardt Attard @attardlab & team @ucl find that prostate cancers with high proliferation rates have shorter survival times but when spread has occurred, there is increased sensitivity to hormone therapy with #abiraterone.
@PCFnews @CR_UK @ProstateUK @UCLCancer
#ProstateCancer #mHSPC

[Larissa Mendes @LarissaSTMendes]

@AllForWoFo

[Ankur Sangoi @slusagar]

👏🏽Dx: malakoplakia!

⬇️VonKossa stain (my fav for👀MG bodies)

✔️recent #GUpath study by @Andres_M_Acosta @Andres_Matoso & I did

PMID: 35876721
https://t.co/1UQkZAOMfs

[Jane Middleton @cinnamontoastuk]

This makes me so angry. When you’re Prime Minister, you don’t volunteer in a soup kitchen. You legislate to ensure soup kitchens aren’t necessary. https://t.co/UmLszTffAU

[The PhD Place @ThePhDPlace]

Annoy a PhD student in one tweet

[Mushtaq Bilal, PhD @MushtaqBilalPhD]

How to build an academic writing habit (to write a lot and publish a lot):

[MarshFamilySongs @MarshSongs]

Sigh.

[Samson W. Fine, MD @rovingatuscap]

Cribriform architecture is sieve-like (mass of cells with multiple spaces) and may be seen in:

Invasive Gleason pattern 4 disease: https://t.co/LS5jjKQa6A

or in

Intraductal carcinoma (surrounded by basal cells): https://t.co/RNpfZobd4v #prostateJC #gupath

[Jerad Gardner, MD @JMGardnerMD]

Molecular Testing Basics explained in 15 minutes (video): https://t.co/CaTqBCVhEY. A simple explanation of the main types of molecular tests #pathologists use, when we use them, & why. #pathology #pathTwitter #MedTwitter #MedEd #MolPath #dermtwitter #dermpath

[Joachim Goedhart @joachimgoedhart]

This online resource that introduces data visualization using #rstats & ggplot2 has 12 complete protocols available for a variety of plots.
https://t.co/UteSDLQT9r

[Jacob Berchuck @jberchuck]

❌Missed the ESMO 2022 meeting? Not to worry...

⬇️Check out our summary of all the clinical updates in prostate, bladder, kidney, and testicular cancer presented by the DFCI Lank Center for GU Oncology faculty.

📽:https://t.co/RZiJlQOctw

[Larissa Mendes @LarissaSTMendes]

😂

[Barry McGinn @DrBMcGinn]

When you bring 2 trays of IHC to the emeritus pathology professor but he’s already made the diagnosis on H+E

[Nick James @Prof_Nick_James]

#STAMPEDE data we present today shows 1. Different response rates in nodes and bone to doce and abi. 2. Lymph node number is independently prognostic for both abi and doce @MRCCTU

[Larissa Mendes @LarissaSTMendes]

@Somaieh_Hedayat @ElisaFontana83 @ICR_London Well done Somaieh!!!! Much, much deserved! 👏👏👏👏

[AttardLab @AttardLab]

It's a #STAMPEDE double bill kicking off the prostate proffered paper session at #ESMO22 with Gert presenting LBA62 and @marina_parry with 1358O. Hope to see you there, Sunday 11th, 8.30am Antibes auditorium.

[Larissa Mendes @LarissaSTMendes]

@Mango

[Alessandra Nieri @AlessandraNieri]

I don’t understand why companies still use EVRi / Hermes delivery. It was shit, it is shit and by the looks of it, even with a rebrand, it will always be shit. There is - literally - no way to contact customer service 🫠

[AttardLab @AttardLab]

Thrilled to share our 1st translational study looking at accumulation of copy number alterations & clinical progression in #STAMPEDE (https://t.co/r3RFgDXtU7). Thanks to funders @ProstateUK @CRUKresearch @PCF_Science @PCR_News & @EmilyGrist1 for driving this. Tweetorial to come!

[Esther Youd @estheryoud]

As a a consultant colleague at the same university, this is utterly shameful😡

[Histopathology @Histo_Journal]

Best methodology for Ki-67 scoring in breast carcinoma. #breastcancer #breastpath https://t.co/o8QEaYQYGj